Inhalis is committed to improve patients’ life with safer and more effective treatment options. Solid science and industry-leading delivery technology are combined with an experienced management team to research and develop new inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Corso Elvezia, 4, Lugano,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://inhalis.com/
- Keywords
- InkVivo Technologies AG.
- HQ
- Lugano
Inhalis Therapeutics Questions
Inhalis Therapeutics's website is https://inhalis.com/
Inhalis Therapeutics's LinkedIn profile is https://ch.linkedin.com/company/inhalis-therapeutics
Inhalis Therapeutics has
6 employees.
View email and phone details for 6
employees at Inhalis Therapeutics.
Inhalis Therapeutics's industry is
Biotechnology Research
Inhalis Therapeutics's top competitors are
Nxi Therapeutics Ag,
Atopia Therapeutics,
Adya,
Inkvivo Technologies Ag,
Palladio Group,
Pdc Therapeutics,
Esocap Ag,
Inseit,
Laevoroc,
Healiva®.
Inhalis Therapeutics's categories are Biotechnology Research
Inhalis Therapeutics's founding year is 2023
